Hydrogen Therapy Shows Promise for Bone Marrow Transplant Complications
- Authors
- Li-Ren Qian, Xiaopeng Liu, Jianliang Shen, Defeng Zhao, Wenjie Yin
- Journal
- Journal of Cellular and Molecular Medicine
- Year
- 2017
- DOI
- 10.1111/jcmm.13155
- Study Type
- Mouse
- Outcome
- Positive
- Peer Reviewed
- Yes
- Country
- China
- Health Condition
- Chronic Graft-Versus-Host Disease
- Body System
- Immune System
TL;DR
A study found that treating mice with hydrogen-rich saline improved their survival and reduced skin damage after a bone marrow transplant that can lead to a serious condition called chronic graft-versus-host disease.
Key Finding
Hydrogen-rich saline increased survival rates and reduced skin lesions in mice with chronic graft-versus-host disease following bone marrow transplantation.
Summary
This study tested whether hydrogen-rich saline could help mice with chronic graft-versus-host disease (cGVHD)—a serious condition where immune cells from a bone marrow transplant attack the recipient's own body. Researchers gave hydrogen-rich saline to transplanted mice and found that it increased survival rates and reduced skin damage compared to untreated mice, likely by reducing inflammation and scarring.
Practical Takeaway
While this mouse study suggests hydrogen may have anti-inflammatory and anti-scarring properties relevant to transplant complications, it is very early-stage research. These results cannot be directly applied to humans yet, and clinical trials would be needed to determine if hydrogen-rich saline could help transplant patients. Anyone considering hydrogen interventions after transplantation should consult their transplant team.
Abstract (excerpt)
The incidence of chronic graft-versus-host disease (cGVHD) is rising recent years, which has been the leading cause of non-transplantation mortality post allogenetic hematopoietic stem cell transplantation (HSCT). Imbalance of inflammatory cytokines and fibrosis plays critical roles…